IA2030 Scorecard
—Global
Type to select a Country
Antigen | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Mean | 71% | 69% | 68% | 72% |
DTP3 | 86% | 83% | 81% | 84% |
HPV | 14% | 12% | 13% | 15% |
HEPB3 | 86% | 83% | 81% | 84% |
HIB3 | 74% | 72% | 72% | 76% |
IPV1 | 85% | 82% | 81% | 85% |
MCV1 | 86% | 83% | 81% | 83% |
MCV2 | 71% | 72% | 71% | 74% |
PCV3 | 51% | 51% | 51% | 60% |
POL3 | 87% | 83% | 81% | 84% |
RCV1 | 69% | 68% | 66% | 68% |
ROTAC | 40% | 47% | 48% | 51% |
Step 1) Calculate the average of the coverage achieved at the level of interest (e.g., country level, global, WHO regional, etc.)